Description
This peptide is an epitope of carcinoembryonic antigen and is recognized by T cells in the immune system; it may have potential in the development of vaccines or targeting therapies.
Product Unit Size | Cost | Quantity | Stock |
---|
This peptide is an epitope of carcinoembryonic antigen and is recognized by T cells in the immune system; it may have potential in the development of vaccines or targeting therapies.
Purity | ≥95% |
---|---|
Formula | C43H69N11O14 |
Formula Wt. | 964.09 |
Synonym | CEA (605-613) |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 1;180(3):1526-34. PMID: 18209048.
Tosi D, Valenti R, Cova A, et al. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol. 2004 May 1;172(9):5363-70. PMID: 15100276.
PKC activator, carcinogen.
VEGFR2, PDGFR, FGFR2 inhibitor.
BACE1 inhibitor
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
Estradiol metabolite.
Fluoroquinolone; bacterial DNA gyrase and helic...
Caffeic acid derivative.
Vitamin A derivative, palmitic acid ester of re...
Hedgehog and Smo agonist.
5-HT1A agonist, α1-adrenergic antagonist.
Nicotinic acid derivative; InhA inhibitor.
Isoleucyl-tRNA synthase inhibitor, osteoclast p...
STING activator
Endogenous bile acid; FXR agonist.